Belatacept for Renal Transplant Recipients With Delayed Graft Function

NCT02134288 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Drug unavailability due to a manufacturing transition.

Conditions

Delayed Graft Function

Interventions

DRUG: Belatacept
DRUG: Everolimus

Sponsor

Ohio State University

Collaborators

[object Object]